Accepted: June 5, 2025
If patients experience persistent difficulty with injections, inconsistent medication effects, or injection site reactions, they should contact their healthcare provider for additional guidance
Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D
In summary, TZP proved to hasten the achievement of glycemic targets in T2D patients in comparison to semaglutide and titrated insulin degludec
For example, the popular diabetes drugs Victoza, also from Novo Nordisk, and Jardiance have been approved as treatments to reduce the risk of heart attack, stroke and death in heart patients
Mounjaro ~22.5% average body weight loss Significant weight reduction Improves blood sugar levels Clinically proven weight loss Wegovy ~16.9% average body weight loss Boosts metabolic & cardiovascular health Proven, long-established safety profile Weekly injection, easy to use